Synthetic therapeutic peptides: science and market
P Vlieghe, V Lisowski, J Martinez, M Khrestchatisky - Drug discovery today, 2010 - Elsevier
The decreasing number of approved drugs produced by the pharmaceutical industry, which
has been accompanied by increasing expenses for R&D, demands alternative approaches …
has been accompanied by increasing expenses for R&D, demands alternative approaches …
[PDF][PDF] Synthetic therapeutic peptides: science and market
P Vlieghe, V Lisowski, J Martinez… - Drug Discovery …, 2010 - csmres.co.uk
The decreasing number of approved drugs produced by the pharmaceutical industry, which
has been accompanied by increasing expenses for R&D, demands alternative approaches …
has been accompanied by increasing expenses for R&D, demands alternative approaches …
[引用][C] Synthetic therapeutic. peptides: science and market
P VLIEGHE, V LISOWSKI, J MARTINEZ… - Drug discovery …, 2010 - pascal-francis.inist.fr
Synthetic therapeutic. peptides:science and market CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Synthetic therapeutic peptides: science and market
P Vlieghe, V Lisowski, J Martinez… - Drug Discovery …, 2010 - infona.pl
The decreasing number of approved drugs produced by the pharmaceutical industry, which
has been accompanied by increasing expenses for R&D, demands alternative approaches …
has been accompanied by increasing expenses for R&D, demands alternative approaches …
[PDF][PDF] Synthetic therapeutic peptides: science and market
P Vlieghe, V Lisowski, J Martinez… - Drug Discovery …, 2010 - Citeseer
The decreasing number of approved drugs produced by the pharmaceutical industry, which
has been accompanied by increasing expenses for R&D, demands alternative approaches …
has been accompanied by increasing expenses for R&D, demands alternative approaches …
Synthetic therapeutic peptides: science and market
P Vlieghe, V Lisowski, J Martinez… - Drug discovery …, 2010 - pubmed.ncbi.nlm.nih.gov
The decreasing number of approved drugs produced by the pharmaceutical industry, which
has been accompanied by increasing expenses for R&D, demands alternative approaches …
has been accompanied by increasing expenses for R&D, demands alternative approaches …
[引用][C] Synthetic therapeutic peptides: science and market
P Vlieghe, V Lisowski, J Martinez… - Drug Discovery …, 2010 - cir.nii.ac.jp
Synthetic therapeutic peptides: science and market.
P Vlieghe, V Lisowski, J Martinez… - Drug Discovery …, 2009 - europepmc.org
The decreasing number of approved drugs produced by the pharmaceutical industry, which
has been accompanied by increasing expenses for R&D, demands alternative approaches …
has been accompanied by increasing expenses for R&D, demands alternative approaches …
[PDF][PDF] Synthetic therapeutic peptides: science and market
P Vlieghe, V Lisowski, J Martinez, M Khrestchatisky - Citeseer
The binding of beryllium by bovine serum albumin was investigated, at three temperatures,
in the pH region 5 and below, where beryllium salts are soluble and dialyzable. Reversible …
in the pH region 5 and below, where beryllium salts are soluble and dialyzable. Reversible …
Synthetic therapeutic peptides: science and market
P Vlieghe, V Lisowski, J Martinez… - Drug Discovery …, 2010 - infona.pl
The decreasing number of approved drugs produced by the pharmaceutical industry, which
has been accompanied by increasing expenses for R&D, demands alternative approaches …
has been accompanied by increasing expenses for R&D, demands alternative approaches …